Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.58% | 149.06 | 0.7% | $734.24m | |
| BMY | Bristol-Myers Squibb Co. | -0.08% | 66.73 | 1.0% | $726.64m | |
| PFE | Pfizer Inc. | -0.25% | 40.51 | 0.9% | $611.72m | |
| MRK | Merck & Co., Inc. | -0.22% | 90.98 | 0.7% | $577.92m | |
| ABBV | AbbVie, Inc. | -1.40% | 88.01 | 2.3% | $545.73m | |
| LLY | Eli Lilly & Co. | -1.29% | 139.61 | 1.1% | $400.65m | |
| APLS | Apellis Pharmaceuticals, Inc. | 0.30% | 40.50 | 0.0% | $107.43m | |
| NVS | Novartis AG | 0.88% | 95.94 | 0.2% | $101.60m | |
| AZN | AstraZeneca Plc | 1.62% | 51.33 | 1.2% | $98.49m | |
| GSK | GlaxoSmithKline Plc | 1.55% | 47.89 | 0.2% | $84.36m | |
| KRTX | Karuna Therapeutics, Inc. | 9.17% | 104.52 | 0.0% | $68.78m | |
| SNY | Sanofi | 0.10% | 51.24 | 0.2% | $68.67m | |
| NVO | Novo Nordisk A/S | -0.02% | 61.30 | 0.1% | $64.41m | |
| RETA | Reata Pharmaceuticals, Inc. | -2.24% | 211.43 | 3.5% | $64.03m | |
| TPTX | Turning Point Therapeutics, Inc. | 2.72% | 59.95 | 0.0% | $40.48m |
Company Profile
AstraZeneca Plc is a holding company, which engages in the research, development and manufacturing of pharmaceutical products. The company produces and commercializes medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology, and infectious diseases. Its pipeline consists of azd 4831, azd 8601, medi 6012, tagrisso bloom, durvalumab, selumetinib, lyparza polo, epanova, farxiga and brilinta. The company distributes its products under the following brands: Atacand, Crestor, Onglyza, Nexium, Entocort, Losec, Merrem/Meronem, Carbocaine, Citanest, Diprivan, Marcaine/Sensorcaine. AstraZeneca was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.